RNA-4359 has advanced into the Phase 2 portion of the ongoing Phase 1/2 trial CAMBRIDGE, MA / ACCESS Newswire / October 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that clinical, safety and ...
BOSTON, MA / ACCESS Newswire / October 12, 2025 / Up to 240 million people worldwide live with obsessive compulsive disorder (OCD), a serious mental health condition marked by intrusive thoughts and ...
Artificial intelligence (AI) is rapidly transforming biomarker discovery by unlocking insights from vast and complex datasets ...
FutureWise Research, a leading healthcare and life sciences market intelligence firm, today announces the release of its ...
Technological Advancements Drive Innovation in Medical Radiation Shielding SolutionsThe Global Medical Radiation Shielding ...
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...
MMJ BioPharma CEO Duane Boise summed it up bluntly:"Milgram's DEA was a monument to incompetence and indifference - and ...
Delivering over two million hours of care while creating meaningful jobs for family caregivers. PHILADELPHIA, PA / ACCESS ...
The drug screening market represents a critical segment of the healthcare and diagnostics industry, encompassing technologies ...
DirectPlate™ creates a one-step metal refining technique from impure mined raw materials and select recycling streams, ...
Highlighting the Solutions Transforming Data Accuracy, Automation, and AI-Driven Revenue Integrity at the Minneapolis ...
LAS CRUCES, NEW MEXICO / ACCESS Newswire / October 9, 2025 / The healthcare industry is approaching a breaking point. Across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback